N. Guiso
Unité de Prévention et Thérapies Moléculaires des Maladies Humaines-FRE-CNRS 2849
Institut Pasteur
25 rue du Dr. Roux
75724 Paris Cedex 15
France
Name/email consistency: high
- Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Guiso, N., Njamkepo, E., Vié le Sage, F., Zepp, F., Meyer, C.U., Abitbol, V., Clyti, N., Chevallier, S. Vaccine (2007)
- Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. Guiso, N., Boursaux-Eude, C., Weber, C., Hausman, S.Z., Sato, H., Iwaki, M., Kamachi, K., Konda, T., Burns, D.L. Vaccine (2001)
- Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Guiso, N., Capiau, C., Carletti, G., Poolman, J., Hauser, P. Vaccine (1999)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








